Kezar Life Sciences Inc.(KZR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KZR Kezar Life Sciences Inc.

盘后交易 12-19 16:08:02 EST

6.34

+0.02

+0.32%

盘后6.34

+0.000.00%

16:00 EST

最高6.38	最低6.27	成交量6.79万
今开6.32	昨收6.32	日振幅1.74%
总市值4,643万	流通市值2,974万	总股本732.32万
成交额43.05万	换手率1.45%	流通股本469.15万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KZR","market":"US","secType":"STK","nameCN":"Kezar Life Sciences Inc.","latestPrice":6.34,"timestamp":1766178000000,"preClose":6.32,"halted":0,"volume":67905,"hourTrading":{"tag":"盘后","latestPrice":6.34,"preClose":6.34,"latestTime":"16:00 EST","volume":270,"amount":1711.8,"timestamp":1766178009719},"delay":0,"floatShares":4691522,"shares":7323156,"eps":-8.441156,"marketStatus":"盘后交易","change":0.02,"latestTime":"12-19 16:08:02 EST","open":6.32,"high":6.38,"low":6.2701,"amount":430548.596775,"amplitude":0.017389,"askPrice":6.34,"askSize":220,"bidPrice":6.19,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-8.441156,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766192400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":6.32,"postHourTrading":{"tag":"盘后","latestPrice":6.34,"preClose":6.34,"latestTime":"16:00 EST","volume":270,"amount":1711.8,"timestamp":1766178009719},"volumeRatio":2.278737,"impliedVol":6.811,"impliedVolPercentile":0.98},"requestUrl":"/m/hq/s/KZR","defaultTab":"news","newsList":[{"id":"1194400922","title":"Kezar Life Sciences Inc - 将裁员70%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194400922","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194400922?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:15","pubTimestamp":1763572516,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences Inc 宣布将裁员70%。此外，公司预计将面临600万美元的重组成本，并预计在2025年第四季度确认这些费用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"1118313091","title":"Kezar Life Sciences公布关于Zetomipzomib在自身免疫性肝炎项目的监管更新并计划探索战略替代方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1118313091","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118313091?lang=zh_cn&edition=full","pubTime":"2025-10-17 04:06","pubTimestamp":1760645171,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences公布关于Zetomipzomib在自身免疫性肝炎项目的监管更新并计划探索战略替代方案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2556684377","title":"Kezar Life Sciences, Inc.盘中异动 下午盘急速下挫5.85%报4.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556684377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556684377?lang=zh_cn&edition=full","pubTime":"2025-08-02 03:29","pubTimestamp":1754076551,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日03时29分，Kezar Life Sciences, Inc.股票出现异动，股价快速跳水5.85%。截至发稿，该股报4.02美元/股，成交量3.3857万股，换手率0.46%，振幅3.96%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Equillium, Inc.、4D Molecular Therapeutics, Inc.、Sensei Biotherapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Equillium, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为1772.70%、350.52%、303.29%，振幅较大的相关个股有Equillium, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、天境生物，振幅分别为253.15%、72.18%、59.20%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802032911a6ce46f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802032911a6ce46f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2551512536","title":"Kezar Life Sciences, Inc.盘中异动 股价大跌5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551512536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551512536?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:34","pubTimestamp":1752672846,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时34分，Kezar Life Sciences, Inc.股票出现波动，股价急速跳水5.90%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Qualigen Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026涨幅较大，Qualigen Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为1592.08%、884.94%、382.47%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Windtree Therapeutics, Inc.，振幅分别为34.27%、23.35%、20.52%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071621340697a88374&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071621340697a88374&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2550693969","title":"Kezar Life Sciences, Inc.盘中异动 股价大跌5.43%报4.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550693969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550693969?lang=zh_cn&edition=full","pubTime":"2025-07-12 03:55","pubTimestamp":1752263732,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日03时55分，Kezar Life Sciences, Inc.股票出现异动，股价急速跳水5.43%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。其相关个股中，Mink Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、康乃德生物涨幅较大，Mink Therapeutics, Inc.、Cel-Sci Corporation、Dare Bioscience, Inc.较为活跃，换手率分别为1171.39%、521.80%、91.96%，振幅较大的相关个股有Mink Therapeutics, Inc.、Cel-Sci Corporation、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为721.86%、96.34%、86.50%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712035532953f287d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712035532953f287d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2547150300","title":"Kezar Life Sciences, Inc.盘中异动 临近午盘大幅上涨5.41%报4.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547150300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547150300?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:37","pubTimestamp":1751297844,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日23时37分，Kezar Life Sciences, Inc.股票出现异动，股价快速拉升5.41%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为4188.76%、316.93%、105.97%，振幅较大的相关个股有Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为164.65%、56.94%、50.00%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233724a4c6f726&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233724a4c6f726&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2546582432","title":"Kezar Life Sciences, Inc.盘中异动 临近收盘股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546582432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546582432?lang=zh_cn&edition=full","pubTime":"2025-06-25 03:59","pubTimestamp":1750795160,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日03时59分，Kezar Life Sciences, Inc.股票出现异动，股价快速上涨5.40%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为1.88%。其相关个股中，内克塔治疗、Apollomics Inc C/Wts 01/04/2028 、Eyenovia, Inc.涨幅较大，Eyenovia, Inc.、Nucana Plc、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1436.71%、1050.91%、550.18%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Immatics N V C/Wts 01/07/2025 、内克塔治疗，振幅分别为191.38%、156.58%、116.56%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625035920a71bbb53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625035920a71bbb53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2544214908","title":"Kezar Life Sciences, Inc.盘中异动 早盘大幅拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544214908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544214908?lang=zh_cn&edition=full","pubTime":"2025-06-18 21:35","pubTimestamp":1750253717,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日21时35分，Kezar Life Sciences, Inc.股票出现异动，股价大幅拉升5.13%。截至发稿，该股报4.30美元/股，成交量8533股，换手率0.12%，振幅2.44%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Aptevo Therapeutics Inc.、Biodexa Pharmaceuticals Plc、Geovax Labs, Inc.涨幅较大，Aptevo Therapeutics Inc.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃，换手率分别为2932.37%、657.61%、163.57%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Biomx Inc.，振幅分别为54.26%、20.59%、17.92%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618213517a710976d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618213517a710976d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2543609833","title":"Kezar Life Sciences, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543609833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543609833?lang=zh_cn&edition=full","pubTime":"2025-06-16 23:05","pubTimestamp":1750086338,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日23时05分，Kezar Life Sciences, Inc.股票出现异动，股价快速跳水5.01%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Sage Therapeutics, Inc.、Alaunos Therapeutics, Inc.、Nucana Plc涨幅较大，Nucana Plc、Processa Pharmaceuticals, Inc.、Matinas Biopharma Holdings, Inc.较为活跃，换手率分别为2217.04%、201.78%、74.03%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Matinas Biopharma Holdings, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 ，振幅分别为58.78%、41.67%、35.62%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616230538a4ac5ad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616230538a4ac5ad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2543631366","title":"Kezar Life Sciences, Inc.盘中异动 股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543631366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543631366?lang=zh_cn&edition=full","pubTime":"2025-06-14 01:15","pubTimestamp":1749834942,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日01时15分，Kezar Life Sciences, Inc.股票出现波动，股价大幅下挫5.43%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Vaxart, Inc. - Common Stock、乌龙制药、Enliven Therapeutics, Inc.涨幅较大，Nucana Plc、Alzamend Neuro, Inc.、Onconetix, Inc.较为活跃，换手率分别为1486.75%、79.24%、46.85%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、凯信远达、Vaxart, Inc. - Common Stock，振幅分别为78.14%、65.84%、51.75%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614011543951b5c5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614011543951b5c5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2542738510","title":"Kezar Life Sciences, Inc.盘中异动 早盘急速上涨5.22%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542738510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542738510?lang=zh_cn&edition=full","pubTime":"2025-06-12 22:14","pubTimestamp":1749737686,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日22时14分，Kezar Life Sciences, Inc.股票出现波动，股价快速上涨5.22%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Klotho Neurosciences, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Nucana Plc、Klotho Neurosciences, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为1832.93%、146.57%、114.79%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为66.62%、65.64%、56.64%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612221446a705797b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612221446a705797b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2542802345","title":"Kezar Life Sciences, Inc.盘中异动 早盘股价大涨5.17%报4.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542802345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542802345?lang=zh_cn&edition=full","pubTime":"2025-06-10 23:02","pubTimestamp":1749567735,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日23时02分，Kezar Life Sciences, Inc.股票出现波动，股价大幅拉升5.17%。截至发稿，该股报4.68美元/股，成交量9974股，换手率0.14%，振幅4.27%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大，Nucana Plc、Windtree Therapeutics, Inc.、Evogene Ltd.较为活跃，换手率分别为23751.99%、2586.94%、1153.45%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Nucana Plc，振幅分别为253.85%、191.40%、99.74%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610230215951672b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610230215951672b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2518839577","title":"Kezar Life Sciences, Inc.盘中异动 临近收盘急速下挫5.57%报5.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518839577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518839577?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:59","pubTimestamp":1741636760,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时59分，Kezar Life Sciences, Inc.股票出现波动，股价快速跳水5.57%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Checkpoint Therapeutics, Inc.、Protagonist Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6563.40%、3904.41%、1042.76%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103592098a2e63c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103592098a2e63c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2517929021","title":"Kezar Life Sciences, Inc.盘中异动 股价大涨5.17%报6.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517929021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517929021?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:59","pubTimestamp":1741208390,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时59分，Kezar Life Sciences, Inc.股票出现波动，股价急速上涨5.17%。截至发稿，该股报6.10美元/股，成交量6717股，换手率0.09%，振幅5.95%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为1.84%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045951963b2fc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045951963b2fc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2516370340","title":"Kezar Life Sciences, Inc.盘中异动 下午盘急速跳水5.60%报5.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516370340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516370340?lang=zh_cn&edition=full","pubTime":"2025-03-01 02:14","pubTimestamp":1740766482,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日02时14分，Kezar Life Sciences, Inc.股票出现波动，股价大幅下挫5.60%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Enveric Biosciences, Inc.、Camp4 Therapeutics Corporation、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3170.54%、527.50%、377.17%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.90%、48.19%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301021443a25836fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301021443a25836fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2513179652","title":"Kezar Life Sciences, Inc.盘中异动 临近收盘急速跳水5.47%报6.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513179652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513179652?lang=zh_cn&edition=full","pubTime":"2025-02-22 05:00","pubTimestamp":1740171624,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日05时00分，Kezar Life Sciences, Inc.股票出现异动，股价急速下挫5.47%。截至发稿，该股报6.05美元/股，成交量7415股，换手率0.10%，振幅5.00%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Moolec Science Sa C/Wts 涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为333.81%、257.65%、139.71%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为77.39%、70.25%、61.26%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222050025abd7fe18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222050025abd7fe18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2512548598","title":"Kezar Life Sciences, Inc.盘中异动 早盘股价大涨5.42%报6.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512548598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512548598?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:30","pubTimestamp":1739975458,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时30分，Kezar Life Sciences, Inc.股票出现波动，股价大幅拉升5.42%。截至发稿，该股报6.22美元/股，成交量343股，换手率0.00%，振幅0.00%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Cellectar Biosciences, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为201.75%、200.71%、65.44%，振幅较大的相关个股有Azitra Inc、Cellectar Biosciences, Inc.、Kala Bio, Inc.，振幅分别为11.29%、6.05%、4.99%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223058988b3128&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223058988b3128&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2509256337","title":"Kezar Life Sciences, Inc.盘中异动 下午盘股价大涨5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509256337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509256337?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:28","pubTimestamp":1738787325,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时28分，Kezar Life Sciences, Inc.股票出现异动，股价大幅拉升5.93%。截至发稿，该股报6.61美元/股，成交量2.6862万股，换手率0.37%，振幅4.33%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为2.29%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Invivyd, Inc.、Transcode Therapeutics, Inc.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4685.41%、2432.32%、1778.04%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Invivyd, Inc.，振幅分别为132.24%、99.51%、96.79%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020604284696194083&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020604284696194083&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2500121855","title":"Kezar Life Sciences, Inc.盘中异动 股价大涨5.02%报6.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500121855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500121855?lang=zh_cn&edition=full","pubTime":"2025-01-04 04:40","pubTimestamp":1735936837,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日04时40分，Kezar Life Sciences, Inc.股票出现异动，股价急速拉升5.02%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Scorpius Holdings, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为1868.52%、1757.16%、351.54%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.，振幅分别为143.91%、123.70%、107.01%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010404403795f806f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010404403795f806f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2494757896","title":"Kezar Life Sciences, Inc.盘中异动 股价大涨5.00%报6.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494757896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494757896?lang=zh_cn&edition=full","pubTime":"2024-12-27 02:44","pubTimestamp":1735238654,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日02时44分，Kezar Life Sciences, Inc.股票出现波动，股价快速拉升5.00%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Moolec Science Sa C/Wts 涨幅较大，Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为2151.09%、472.74%、117.83%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Scisparc Ltd.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为264.57%、198.24%、131.78%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122702441498507838&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122702441498507838&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kezarlifesciences.com","stockEarnings":[{"period":"1week","weight":0.0032},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.6809},{"period":"6month","weight":0.3982},{"period":"1year","weight":0.0048},{"period":"ytd","weight":-0.0595}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kezar Life Sciences, Inc.于2015年2月19日根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，开发新型小分子疗法，用于治疗免疫介导疾病和癌症中未满足的需求。该公司正在推进两个利用细胞功能不同调节因子的药物开发计划：第一个针对负责免疫系统细胞中蛋白质降解并驱动免疫细胞功能的许多关键方面的免疫蛋白酶体，第二个针对Sec61转座子。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.09183},{"month":2,"riseRate":0.714286,"avgChangeRate":0.077321},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.102159},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.082421},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.16242},{"month":6,"riseRate":0.428571,"avgChangeRate":0.046939},{"month":7,"riseRate":0.25,"avgChangeRate":-0.059399},{"month":8,"riseRate":0.5,"avgChangeRate":-0.012192},{"month":9,"riseRate":0.375,"avgChangeRate":0.031351},{"month":10,"riseRate":0.375,"avgChangeRate":0.02054},{"month":11,"riseRate":0.75,"avgChangeRate":0.152848},{"month":12,"riseRate":0.5,"avgChangeRate":0.035332}],"exchange":"NASDAQ","name":"Kezar Life Sciences Inc.","nameEN":"Kezar Life Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kezar Life Sciences Inc.(KZR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kezar Life Sciences Inc.(KZR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kezar Life Sciences Inc.,KZR,Kezar Life Sciences Inc.股票,Kezar Life Sciences Inc.股票老虎,Kezar Life Sciences Inc.股票老虎国际,Kezar Life Sciences Inc.行情,Kezar Life Sciences Inc.股票行情,Kezar Life Sciences Inc.股价,Kezar Life Sciences Inc.股市,Kezar Life Sciences Inc.股票价格,Kezar Life Sciences Inc.股票交易,Kezar Life Sciences Inc.股票购买,Kezar Life Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kezar Life Sciences Inc.(KZR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kezar Life Sciences Inc.(KZR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}